Hemispherx Biopharma, Inc. Meets Ampligen Sales Milestone in the 1st Quarter of 2017
Mar 06, 2017 13:34 pm UTC| Business
PHILADELPHIA, March 06, 2017 -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announced today that it has met a major milestone, the commencement of sales of recently manufactured Ampligen in...
Hemispherx Biopharma, Inc. Meets Ampligen Sales Milestone in the 1st Quarter of 2017
Mar 06, 2017 13:34 pm UTC| Business
PHILADELPHIA, March 06, 2017 -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announced today that it has met a major milestone, the commencement of sales of recently manufactured Ampligen in...
Hemispherx Biopharma, Inc. Meets Ampligen Sales Milestone in the 1st Quarter of 2017
Mar 06, 2017 13:34 pm UTC| Business
PHILADELPHIA, March 06, 2017 -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announced today that it has met a major milestone, the commencement of sales of recently manufactured Ampligen in...
Mar 06, 2017 13:34 pm UTC| Business
EWING, N.J., March 06, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced it will release its fourth quarter and full year 2016 financial results and recent operating progress before the market opens on Tuesday,...
Mar 06, 2017 13:34 pm UTC| Business
EWING, N.J., March 06, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced it will release its fourth quarter and full year 2016 financial results and recent operating progress before the market opens on Tuesday,...
Mar 06, 2017 13:34 pm UTC| Business
EWING, N.J., March 06, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced it will release its fourth quarter and full year 2016 financial results and recent operating progress before the market opens on Tuesday,...
Mar 06, 2017 13:34 pm UTC| Business
EWING, N.J., March 06, 2017 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced it will release its fourth quarter and full year 2016 financial results and recent operating progress before the market opens on Tuesday,...